STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 98 filers reported holding STOKE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $502,669 | -1.1% | 127,581 | +166.9% | 0.01% | 0.0% |
Q2 2023 | $508,071 | -51.4% | 47,796 | -62.0% | 0.01% | -55.2% |
Q1 2023 | $1,046,456 | +29.5% | 125,625 | +43.5% | 0.03% | +26.1% |
Q4 2022 | $807,893 | +26.2% | 87,529 | +75.6% | 0.02% | 0.0% |
Q3 2022 | $640,000 | -42.1% | 49,856 | -40.4% | 0.02% | -54.0% |
Q2 2022 | $1,105,000 | +225.0% | 83,657 | +418.1% | 0.05% | +212.5% |
Q1 2022 | $340,000 | -46.3% | 16,146 | -38.8% | 0.02% | -59.0% |
Q4 2021 | $633,000 | +110.3% | 26,399 | +195.0% | 0.04% | +56.0% |
Q2 2021 | $301,000 | -2.0% | 8,949 | +13.3% | 0.02% | -10.7% |
Q1 2021 | $307,000 | – | 7,896 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 296,822 | $7,551,000 | 1.86% |
RTW INVESTMENTS, LP | 3,644,248 | $92,710,000 | 1.40% |
Cormorant Asset Management, LP | 1,278,276 | $32,519,000 | 1.32% |
Redmile Group, LLC | 2,381,958 | $60,597,000 | 1.06% |
HighVista Strategies LLC | 47,594 | $1,211,000 | 0.80% |
Birchview Capital, LP | 15,000 | $382,000 | 0.26% |
GILDER GAGNON HOWE & CO LLC | 1,123,355 | $28,578,000 | 0.15% |
Artal Group S.A. | 250,000 | $6,360,000 | 0.14% |
Tekla Capital Management LLC | 99,263 | $2,525,000 | 0.08% |
Casdin Capital, LLC | 120,000 | $3,053,000 | 0.08% |